Lipid results partial ileal bypass patients heterozygous type II-A hyperlipoproteinemia Program Surgical Control Hyperlipidemias reduction total plasma cholesterol beneficial effect overall mortality weight experimental epidemiologic evidence supports efforts total plasma cholesterol levels risk death coronary heart disease CHD true patients heterozygous type II-A hyperlipoproteinemia total plasma cholesterol levels percentile age sex risk death CHD lipid results partial ileal bypass PIB patients heterozygous type II-A hyperlipoproteinemia Program Surgical Control Hyperlipidemias prospective clinical trial effects cholesterol reduction overall mortality course CHD dietary control PIB total plasma cholesterol levels mean SEM low-density lipoprotein LDL cholesterol levels high-density lipoprotein HDL cholesterol levels years surgery low-density lipoprotein cholesterol levels triglyceride levels surgical group HDL cholesterol/total plasma cholesterol HDL cholesterol ratios PIB Apolipoprotein A-I HDL subfraction levels levels surgical group PIB mean total plasma cholesterol LDL cholesterol levels limits National Cholesterol Education Program risk death CHD results efficacy role PIB management patients marked hypercholesterolemia 